Universe Pharmaceuticals Files 6-K Report
Ticker: UPC · Form: 6-K · Filed: Feb 11, 2025 · CIK: 1809616
| Field | Detail |
|---|---|
| Company | Universe Pharmaceuticals INC (UPC) |
| Form Type | 6-K |
| Filed Date | Feb 11, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, compliance
TL;DR
Universe Pharma (UPC) filed a 6-K, standard foreign issuer report. No major news.
AI Summary
Universe Pharmaceuticals INC, incorporated in the Cayman Islands, filed a Form 6-K on February 11, 2025. The filing is a report of a foreign private issuer for the month of February 2025. The company's principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
Why It Matters
This filing indicates ongoing reporting compliance for Universe Pharmaceuticals INC as a foreign private issuer, providing routine updates to the SEC.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain material new information or financial disclosures.
Key Players & Entities
- Universe Pharmaceuticals INC (company) — Filer of the 6-K report
- Cayman Islands (jurisdiction) — Place of incorporation
- 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China (location) — Principal executive offices address
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What period does this report cover?
The report is for the month of February 2025.
Where is Universe Pharmaceuticals INC headquartered?
The company's principal executive offices are located at 265 Jingjiu Avenue, Jinggangshan Economic and Technological Development Zone, Ji'an, Jiangxi, China.
Under which laws is Universe Pharmaceuticals INC incorporated?
Universe Pharmaceuticals INC is an exempted company incorporated under the laws of the Cayman Islands.
Does Universe Pharmaceuticals INC file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under cover of Form 20-F.
Filing Stats: 585 words · 2 min read · ~2 pages · Grade level 20 · Accepted 2025-02-11 16:10:07
Filing Documents
- ea0230673-6k_universe.htm (6-K) — 32KB
- ea023067301ex99-1_universe.htm (EX-99.1) — 122KB
- ea023067301ex99-2_universe.htm (EX-99.2) — 31KB
- 0001213900-25-012207.txt ( ) — 186KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.   Universe Pharmaceuticals INC Date: February 11, 2025   By:   /s/ Gang Lai         Gang Lai         Chief Executive Officer 2